QURA develops a series of ultra-miniature implantable devices/tools to monitor physiological pressure changes.
QURA develops a series of ultra-miniature implantable devices/tools to monitor physiological pressure changes. These miniaturized tools will have the potential to transform physiologic monitoring in biomedicine and other applications. In the long term, they envision networks of smart, miniaturized tools that communicate and respond to each other in real-time. Networked devices will interact to both monitor disease and administer timely treatments. The development of these devices has great potential to revolutionize both research abilities and human clinical treatment.It was founded in 2015 and is headquartered in Framingham, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 3, 2018 | Series A | $1M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Santen Ventures | — | Series A |